Tuberculosis in Children Hospitalized in a Low-burden Country: Description and Risk Factors of Severe Disease.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
pubmed:
20
1
2021
medline:
25
9
2021
entrez:
19
1
2021
Statut:
ppublish
Résumé
In high-income countries, few pediatric studies have described the clinical expression of tuberculosis (TB) according to age, and their results are discordant. Patients <2 years of age are usually considered to be at higher risk for severe disease than older children. Our aim was to better describe pediatric TB disease severity in a low-incidence country. All children (<18 years of age) admitted with TB disease to the Robert Debré University Hospital, Paris, between 1992 and 2015 were included. Patients were classified by the severity of TB disease based on the original classification of Wiseman et al. Risk factors associated with severity were analyzed. We included 304 patients with a median age of 9.9 years (interquartile range 3.3-13.3) and a male to female ratio of 1.04. Overall, 280/304 (92%) were classified: 168/304 (55%) were classified as showing severe TB and 112/304 (37%) as showing non-severe TB. Central nervous system disease was more frequent among patients <2 years of age than patients 2-17 years of age (5/54; 9% vs. 5/229; 2% P = 0.024). An age of ≥10 years (P = 0.001) and being born abroad (P = 0.011) were both associated with disease severity in univariate analysis. In multivariate analysis, diagnosis through symptom-based screening was independently associated with severity (odds ratio 7.1, 95% confidence interval: 3.9-12.9, P < 0.0001). This description of the clinical spectrum of pediatric TB in a low-burden setting demonstrates that adolescents are the group most at risk of experiencing severe TB.
Sections du résumé
BACKGROUND
In high-income countries, few pediatric studies have described the clinical expression of tuberculosis (TB) according to age, and their results are discordant. Patients <2 years of age are usually considered to be at higher risk for severe disease than older children. Our aim was to better describe pediatric TB disease severity in a low-incidence country.
METHODS
All children (<18 years of age) admitted with TB disease to the Robert Debré University Hospital, Paris, between 1992 and 2015 were included. Patients were classified by the severity of TB disease based on the original classification of Wiseman et al. Risk factors associated with severity were analyzed.
RESULTS
We included 304 patients with a median age of 9.9 years (interquartile range 3.3-13.3) and a male to female ratio of 1.04. Overall, 280/304 (92%) were classified: 168/304 (55%) were classified as showing severe TB and 112/304 (37%) as showing non-severe TB. Central nervous system disease was more frequent among patients <2 years of age than patients 2-17 years of age (5/54; 9% vs. 5/229; 2% P = 0.024). An age of ≥10 years (P = 0.001) and being born abroad (P = 0.011) were both associated with disease severity in univariate analysis. In multivariate analysis, diagnosis through symptom-based screening was independently associated with severity (odds ratio 7.1, 95% confidence interval: 3.9-12.9, P < 0.0001).
CONCLUSIONS
This description of the clinical spectrum of pediatric TB in a low-burden setting demonstrates that adolescents are the group most at risk of experiencing severe TB.
Identifiants
pubmed: 33464014
doi: 10.1097/INF.0000000000002990
pii: 00006454-202103000-00005
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
199-204Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
World Health Organization.Global tuberculosis report 2019. Geneva, SwitzerlandAvailable at: http://apps.who.int/iris/bitstream/10665/251469/1/9789242548747-fre.pdf?ua=1 . Accessed October 30, 2019.
Trébucq A. Tuberculosis, more than ever a reality. Bull Epidémiol Hebd. Available at: http://beh.santepubliquefrance.fr/beh/2018/6-7/2018_6-7_0.html . Accessed October 30, 2019.
Mathieu P. Épidémiologie de la tuberculose en Île-de-France: une augmentation des cas déclarés en 2016 et en 2017. Bulletin Epidémiologique Hebdomadaire. 2019. Available at: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/tuberculose/documents/article/epidemiologie-de-la-tuberculose-en-ile-de-france-une-augmentation-des-cas-declares-en-2016-et-en-2017 . Accessed October 30, 2019.
Guthmann J. Épidémiologie de la tuberculose en France en 2015. Impact de la suspension de l’obligation vaccinale BCG sur la tuberculose de l’enfant, 2007-2015.2017. Available at: https://www.santepubliquefrance.fr/determinants-de-sante/vaccination/documents/article/epidemiologie-de-la-tuberculose-en-france-en-2015.-impact-de-la-suspension-de-l-obligation-vaccinale-bcg-sur-la-tuberculose-de-l-enfant-2007-2015 . Accessed October 30, 2019.
Marais BJ, Gie RP, Schaaf HS, et al. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med. 2006;173:1078–1090.
Beyers N, Gie RP, Schaaf HS, et al. A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis. Int J Tuberc Lung Dis. 1997;1:38–43.
Galli L, Lancella L, Tersigni C, et al. Pediatric tuberculosis in Italian children: epidemiological and clinical data from the Italian register of pediatric tuberculosis. Int J Mol Sci. 2016;17:960.
Vallejo JG, Ong LT, Starke JR. Clinical features, diagnosis, and treatment of tuberculosis in infants. Pediatrics. 1994;94:1–7.
Gulec SG, Telhan L, Koçkaya T, et al. Description of pediatric tuberculosis evaluated in a referral center in Istanbul Turkey. Yonsei Med J. 2012;53:1176–1182.
Folquet Amorissani M, Gauze JC, Kouakou Kouamé C, et al. [Miliary tuberculosis in children. Report of 89 cases in the pediatric department, Abidjan ]. Mali Med. 2006;21:15–18.
Mukadi YD, Wiktor SZ, Coulibaly IM, et al. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d’Ivoire. AIDS. 1997;11:1151–1158.
Newton SM, Brent AJ, Anderson S, et al. Paediatric tuberculosis. Lancet Infect Dis. 2008;8:498–510.
Mangtani P, Abubakar I, Ariti C, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis. 2014;58:470–480.
Migliori GB, Zellweger JP, Abubakar I, et al. European Union standards for tuberculosis care. Eur Respir J. 2012;39:807–819.
Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 pt 1):1376–1395.
Wiseman CA, Mandalakas AM, Kirchner HL, et al. Novel application of NIH case definitions in a paediatric tuberculosis contact investigation study. Int J Tuberc Lung Dis. 2015;19:446–453.
Wiseman CA, Gie RP, Starke JR, et al. A proposed comprehensive classification of tuberculosis disease severity in children. Pediatr Infect Dis J. 2012;31:347–352.
Insee. IMG1A - Population par sexe, âge et situation quant à l’immigration en 2014 − Région d’Île-de-France (11) −Étrangers - Immigrés en 2014 | Insee 2019.Available at: https://www.insee.fr/fr/statistiques/2874034?sommaire=2874056&geo=REG-11 . Accessed October 30, 2019.
Buzan MT, Pop CM, Raduta M, et al. Respiratory tuberculosis in children and adolescents: assessment of radiological severity pattern and age-related changes within two decades. Pneumologia. 2015;64:8–12.
Harausz EP, Garcia-Prats AJ, Law S, et al.; Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB. Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis. PLoS Med. 2018;15:e1002591.
Osman M, Harausz EP, Garcia-Prats AJ, et al.; Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR TB. Treatment outcomes in global systematic review and patient meta-analysis of children with extensively drug-resistant tuberculosis. Emerg Infect Dis. 2019;25:441–450.
Walters E, Demers AM, van der Zalm MM, et al. Stool culture for diagnosis of pulmonary tuberculosis in children. J Clin Microbiol. 2017;55:3355–3365.
Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392–402.
Lamb GS, Starke JR. Tuberculosis in infants and children. Microbiol Spectr. 2017;5::TNMI7-0037-2016.
Weber HC, Beyers N, Gie RP, et al. The clinical and radiological features of tuberculosis in adolescents. Ann Trop Paediatr. 2000;20:5–10.
de Pontual L, Balu L, Ovetchkine P, et al. Tuberculosis in adolescents: a French retrospective study of 52 cases. Pediatr Infect Dis J. 2006;25:930–932.
Mahomed H, Ehrlich R, Hawkridge T, et al. TB incidence in an adolescent cohort in South Africa. PLoS One. 2013;8:e59652.
Rook GA, Taverne J, Leveton C, et al. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology. 1987;62:229–234.
HCSP. Enquête autour d’un cas de tuberculose. Recommandations pratiques.2013. Paris: Haut Conseil de la Santé Publique; Available at: https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=391 . Accessed October 30, 2019.
Insee. IMG2B - Population immigrée de 15 ans ou plus par sexe, type d’activité et pays de naissance en 2014 − Région d’Île-de-France (11) −Étrangers - Immigrés en 2014 | Insee 2019.Available at: https://www.insee.fr/fr/statistiques/2874042?sommaire=2874056&geo=REG-11 . Accessed October 30, 2019.
Odone A, Tillmann T, Sandgren A, et al. Tuberculosis among migrant populations in the European Union and the European Economic Area. Eur J Public Health. 2015;25:506–512.
ECDC. Programmatic management of latent tuberculosis infection in the European Union.2018Stockholm: ECDC; 49p. (ECDC scientific advice). Available at: https://www.ecdc.europa.eu/en/publications-data/programmatic-management-latent-tuberculosis-infection-european-union . Accessed October 30, 2019.
Rahman N, Pedersen KK, Rosenfeldt V, et al. Challenges in diagnosing tuberculosis in children. Dan Med J. 2012;59:A4463.
HCSP. Infections tuberculeuses latentes. Détection, prise en charge et surveillance 2019.Available at: https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=731 . Accessed October 30, 2019.
Blok N, van den Boom M, Erkens C, et al. Variation in policy and practice of adolescent tuberculosis management in the WHO European Region. Eur Respir J. 2016;48:943–946.
Chabala C, Turkova A, Thomason MJ, et al.; SHINE trial team. Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial. Trials. 2018;19:237.
Seddon JA, Weld ED, Schaaf HS, et al. Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done? Int J Tuberc Lung Dis. 2018;22:24–33.
Seddon JA, Schaaf HS. Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis. Pneumonia (Nathan). 2016;8:20.
Roya-Pabon CL, Perez-Velez CM. Tuberculosis exposure, infection and disease in children: a systematic diagnostic approach. Pneumonia (Nathan). 2016;8:23.